top of page
![Pattern 5 [Converted]-01.png](https://static.wixstatic.com/media/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png/v1/fill/w_980,h_718,al_c,q_90,usm_0.66_1.00_0.01,enc_avif,quality_auto/51c62d_44f38c257d614130ace0f56455e9be12~mv2.png)
Knowledge Center
Search
HeartLung Technologies Secures CMS Reimbursement for AutoChamberâ„¢ with New HCPCS Code
CMS has approved a new HCPCS code for AutoChamberâ„¢ AI reporting cardiac chambers volume and left ventricular mass in existing CT scans.
HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board
HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board.
HeartLung Technologies Presented 3 Groundbreaking AI Studies at BMEII 2025 New York Academy of Medicine
HeartLung showcases AI innovations at BMEII 2025, advancing healthcare with three scientific presentations.
HeartLung Technologies to launch AutoChamberâ„¢ AI at ACC 2025 and begin offering the AI services to healthcare providers
HeartLung Technologies to launch AutoChamberâ„¢ AI at ACC 2025 and begin offering the AI services to healthcare providers
HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge
HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge
SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Osteoporosis Screening (AutoBMDâ„¢ AI) as an add-on to CT Scans Nationwide
SimonMed Imaging partners with HeartLung.AI to roll out AutoBMDâ„¢ AI for osteoporosis screening, enhancing preventive healthcare.
Expert Panel Discusses AI-Driven Innovations in Cardiovascular Imaging: Key Takeaways from RSNA 2024
Experts at RSNA 2024 discuss AI's transformative impact on cardiovascular imaging, featuring insights from HeartLung.AI., Nurea, AI4MedImagi
Part 21 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Reinventing Public Health in the Era of AI
Dr. Cheryl Healton, DrPH, emphasizes AI's role in public health, expanding lung screening, and managing smoking-related illnesses.
Part 20 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Panel Discussions
Panel highlights advanced imaging and AI in early disease detection, emphasizing standardized reporting and insurance for preventive measure
Part 19 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Sess 3: Sex and Race Differences in Visceral Fat and CVD
Dr. Susan K. Fried, PhD, highlights how sex and race differences in visceral fat impact cardiovascular disease and diabetes risk.
Harmonizing Healthcare and Innovation: HeartLung Technologies Welcomes Dr. Robert A. Kloner to the Advisory Board
HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. Discover his contributions to heart health and his music.
Part 18 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Abnormal Adiposity
Dr. Jeffrey Mechanick, MD, redefines abnormal adiposity, linking ectopic fat to cardiometabolic diseases and urging lifestyle changes.
Part 17 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Osteoporosis and Sarcopenia
Dr. Mingqian Huang, MD, emphasizes the critical role of advanced imaging and AI in detecting and managing osteoporosis and sarcopenia.
Part 16 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 3: Fatty Liver Disease
Dr. Andrea D. Branch, PhD, highlights CT screening for liver steatosis, a metabolic syndrome marker, and the role of new drugs in treatment.
HeartLung’s 2024 Year in Review - Milestones and Pipeline for 2025
2024 was a monumental year for HeartLung Technologies. With that being said, we have exciting developments for 2025!
Part 15 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 2: Panel Discussions
Experts in pulmonary medicine stress the early detection of lung diseases, low-dose CT scans, and the role of pulmonologists in patient care
Part 14 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 2: Bronchiectasis
Dr. Metersky stresses the importance of early bronchiectasis diagnosis and treatment, noting the benefits of low-dose CT scans and more.
Part 13 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 2: Interstitial Lung Disease
Dr. Maria Padilla, MD, stresses early ILD diagnosis, highlighting low-dose CT scans for better outcomes and new therapeutic interventions.
Part 12 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 2: Emphysema and COPD
Dr. Rizzo stresses the need for early COPD detection, clear guidelines, and the role of pulmonologists and new drugs in improving outcomes.
Part 11 of 49 - Video Presentations of the "1st Conference on Integrating Early Detection of Heart and Lung Disease through Low-Dose CT": Day 1 Session 2: Introduction
Dr. Mulshine highlights early detection's role in preventing thoracic disease deaths, advocating for screening effectiveness over quantity.
bottom of page